Home
Latest
Finance
IPO
ETF
Tech
Overseas
Video
Research
Download App
简
繁
简
繁
EN
Home
Latest
Finance
IPO
ETF
Tech
Overseas
Video
Research
HOME
·
03880.HK
MEDTIDE (03880.HK): Buys Hangzhou Site for Peptide CDMO Base
Tags:
MEDTIDE
03880.HK
Capacity Expansion
2026-09-24
Medtide (03880.HK): Subsidiary Zhongtai Biochemical's Hangzhou Facility Successfully Passes FDA Pre-License Inspection, Paving Way for Commercial API Production of Hepcludex®
Tags:
MEDTIDE
03880.HK
FDA
2026-07-31
Finance
CHINARES PHARMA (03320.HK): Unit completes 2026 bond issue at 1.48%
Finance
DOBOT (02432.HK): Trustee buys 99,800 H shares under incentive scheme
Finance
CHINARES PHARMA (03320.HK): Pre-bid process starts on unit share issue
Finance
CHI MER LAND (00978.HK): Acquires remaining 50% of Foshan Yiyun
Finance
ESTUN (02715.HK): Zhu Zhangxing named CFO as Wu Kan steps down
Finance
ZIBUYU (02420.HK): Amazon DSP contract capped at two years
Finance
INNOSCIENCE (02577.HK): Trustee buys 2.25m more H shares
Finance
LUFAX (06623.HK): Q3 net loss seen at RMB1.3-1.7bn
Finance
LINMON MEDIA (09857.HK): "A Small Town Remedy" set for CCTV-8, iQIYI
Finance
HUASHI GROUP (01111.HK): ED and CFO Zhang Beixian resigns
Scan QR Code
Download App